Status:
COMPLETED
Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin
Lead Sponsor:
Allergan
Conditions:
Hypotrichosis
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This one-year study evaluates the long-term safety and effectiveness of bimatoprost solution application to the eyelid margin (where the eyelashes meet the skin) to treat hypotrichosis of the eyelashe...
Eligibility Criteria
Inclusion
- Subjects who have inadequate eyelashes due to natural causes and are not satisfied with their eyelash appearance.
- For the post-chemotherapy population: subjects who have inadequate eyelashes following a complete course of chemotherapy treatment and are not satisfied with their eyelash appearance, are considered free of cancer and are well enough to complete the study.
Exclusion
- Subjects with unequal right and left eyelashes, any eye disease or abnormality, eye surgery, permanent eyeliner, eyelash implants, eyelash extension application.
- Any use of over the counter or prescription use eyelash growth products.
- Subjects requiring eye drop medications for glaucoma.
- Females who are pregnant, nursing or planning a pregnancy during the study or who are of childbearing potential and not using a reliable method of contraception.
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
368 Patients enrolled
Trial Details
Trial ID
NCT00907426
Start Date
August 1 2009
End Date
May 1 2011
Last Update
September 19 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego, California, United States
2
London, England, United Kingdom